Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction

This publication has 20 references indexed in Scilit:

• Myocardial infarction triage and intervention project—Phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapy
  Journal of the American College of Cardiology, 1990
• Intracranial hemorrhage after rt-pa and heparin for acute myocardial infarction — The TIMI II pilot and randomized trial combined experience
  Journal of the American College of Cardiology, 1990
• The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: Results from thrombolysis in myocardial infarction phase I, open label studies and the thrombolysis in myocardial infarction phase II pilot study
  Journal of the American College of Cardiology, 1989
• Age variation in the association between angiographic coronary disease and angina from the Coronary Artery Surgery Study (CASS)
  International Journal of Cardiology, 1989
• A community survey of the potential use of thrombolytic agents for acute myocardial infarction
  Annals of Emergency Medicine, 1989
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
  BMJ, 1988
• Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients
  The American Journal of Cardiology, 1988
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988
• Update from the thrombolysis in myocardial infarction trial
  Journal of the American College of Cardiology, 1987
• Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS).
  Circulation, 1981